Ghost Tree Capital’s Amicus Therapeutics FOLD Stock Holding History

Ghost Tree Capital’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-175,000	Closed	-$2.13M	–	59
2023 Q3	$2.13M	Sell	175,000 -25,000	-13%	-$322K	0.7%	45
2023 Q2	$2.51M	Sell	200,000 -275,000	-58%	-$3.26M	0.83%	31
2023 Q1	$5.27M	Buy	+475,000	New	+$5.85M	1.56%	26
2022 Q4	–	Sell	-500,000	Closed	-$5.22M	–	40
2022 Q3	$5.22M	Sell	500,000 -500,000	-50%	-$5.57M	1.47%	25
2022 Q2	$10.7M	Sell	1,000,000 -100,000	-9%	-$824K	5.59%	3
2022 Q1	$10.4M	Buy	1,100,000 +600,000	+120%	+$5.63M	2.26%	7
2021 Q4	$5.78M	Buy	500,000 +235,000	+89%	+$2.62M	2.07%	17
2021 Q3	$2.53M	Hold	265,000	–	–	0.74%	45
2021 Q2	$2.56M	Hold	265,000	–	–	0.7%	39
2021 Q1	$2.62M	Sell	265,000 -335,000	-56%	-$5.19M	0.62%	40
2020 Q4	$13.9M	Hold	600,000	–	–	3.09%	13
2020 Q3	$8.47M	Buy	+600,000	New	+$8.74M	2.45%	13
2020 Q1	–	Sell	-1,250,000	Closed	-$12.2M	–	54
2019 Q4	$12.2M	Sell	1,250,000 -455,000	-27%	-$4.17M	2.32%	13
2019 Q3	$13.7M	Buy	1,705,000 +255,000	+18%	+$2.77M	3.48%	12
2019 Q2	$18.1M	Buy	1,450,000 +150,000	+12%	+$1.9M	3.75%	9
2019 Q1	$17.7M	Buy	1,300,000 +650,000	+100%	+$7.94M	4.62%	5
2018 Q4	$6.23M	Buy	+650,000	New	+$7.14M	2.26%	17
2018 Q2	–	Sell	-750,000	Closed	-$11.3M	–	50
2018 Q1	$11.3M	Buy	+750,000	New	+$11.4M	2.28%	13
2017 Q4	–	Sell	-200,000	Closed	-$3.02M	–	57
2017 Q3	$3.02M	Buy	+200,000	New	+$2.65M	0.64%	49
2015 Q3	–	Sell	-375,000	Closed	-$5.31M	–	85
2015 Q2	$5.31M	Buy	375,000 +25,000	+7%	+$301K	1.72%	21
2015 Q1	$3.81M	Buy	350,000 +50,000	+17%	+$441K	1.37%	33
2014 Q4	$2.5M	Buy	+300,000	New	+$2.06M	1.2%	37
2014 Q3	–	Sell	-600,000	Closed	-$2M	–	77
2014 Q2	$2M	Buy	+600,000	New	+$1.41M	1.41%	28

Other funds holding FOLD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ghost Tree Capital's FOLD Position: Q4 2023 in Review

Ghost Tree Capital sold out of Amicus Therapeutics (FOLD) in Q4 2023, closing a stake of 175,000 shares — an estimated $2.13M sold.

Ghost Tree Capital first reported a position in FOLD in Q2 2014 and held it in 23 quarters. The position peaked at $18.1M in Q2 2019. 228 funds tracked by Wall St. Rank hold FOLD as of Q4 2023.

Ghost Tree Capital reported no remaining Amicus Therapeutics position as of Q4 2023 after selling out during the quarter.
Ghost Tree Capital sold 175,000 Amicus Therapeutics shares in Q4 2023, an estimated $2.13M.
Ghost Tree Capital first reported a position in Amicus Therapeutics in Q2 2014 and held it in 23 quarters.
Ghost Tree Capital's Amicus Therapeutics position peaked at $18.1M in Q2 2019.
228 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2023.

Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.